Resultados de la búsqueda 251-260 de 14795 para pathology

  1. Neuro Update Newsletter v8n2 2011 - MC5520-0311

    Page 1. Page 2. Page 3. Page 4. Page 5. Page 6. Page 7. Page 8.

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  3. Transplant Center de Mayo Clinic - Ensayos clínicos

    Monoclonal antibodies, such as rituximab, may interfere with the ability of cancer cells to grow and spread. Giving chemotherapy before a stem cell transplant ...

  4. Estar en forma - Mayo Clinic

    Estar en forma — de estiramientos, flexibilidad, y ejercicio aeróbido a entrenamiento de fuerza y nutrición deportiva.

  5. Transplant Center de Mayo Clinic - Ensayos clínicos

    Monoclonal antibodies, such as rituximab, may interfere with the ability of cancer cells to grow and spread. Giving chemotherapy before a stem cell transplant ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...

  7. Neurología - Ensayos clínicos - Mayo Clinic

    To describe the clinical features along with treatment outcomes of a cohort of patients with a diagnosis of NMOSD after the latest revised criteria in 2015 by ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  9. Cordoma - Descripción general - Mayo Clinic

    The surgical pathology of notochordal remnants in adult intervertebral disks. American Journal of Surgical Pathology. 2008; doi:10.1097/PAS.0b013e3181757954 ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...